Journal article
Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group
Journal of the American Heart Association, Vol.9(19), pp.e016115-e016115
10/20/2020
DOI: 10.1161/JAHA.120.016115
PMCID: PMC7792379
PMID: 32993438
Abstract
Improvements in cardiovascular disease (CVD) rates among young adults in the past 2 decades have been offset by increasing racial/ethnic and gender disparities, persistence of unhealthy lifestyle habits, overweight and obesity, and other CVD risk factors. To enhance the promotion of cardiovascular health among young adults 18 to 39 years old, the medical and broader public health community must understand the biological, interpersonal, and behavioral features of this life stage. Therefore, the National Heart, Lung, and Blood Institute, with support from the Office of Behavioral and Social Science Research, convened a 2-day workshop in Bethesda, Maryland, in September 2017 to identify research challenges and opportunities related to the cardiovascular health of young adults. The current generation of young adults live in an environment undergoing substantial economic, social, and technological transformations, differentiating them from prior research cohorts of young adults. Although the accumulation of clinical and behavioral risk factors for CVD begins early in life, and research suggests early risk is an important determinant of future events, few trials have studied prevention and treatment of CVD in participants <40 years old. Building an evidence base for CVD prevention in this population will require the engagement of young adults, who are often disconnected from the healthcare system and may not prioritize long-term health. These changes demand a repositioning of existing evidence-based treatments to accommodate new sociotechnical contexts. In this article, the authors review the recent literature and current research opportunities to advance the cardiovascular health of today's young adults.
Details
- Title: Subtitle
- Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group
- Creators
- Holly C. Gooding - Children's Healthcare of AtlantaSamuel S. GiddingAndrew E. Moran - Columbia UniversityNicole Redmond - National Heart Lung and Blood InstituteNorrina B. Allen - Northwestern UniversityFida Bacha - Texas Children's HospitalTrudy L. Burns - University of IowaJanet M. Catov - University of PittsburghMichael A. Grandner - University of ArizonaKathleen Mullan Harris - University of North Carolina at Chapel HillHeather M. Johnson - Boca Raton Regional HospitalMichaela Kiernan - Stanford UniversityTene T. Lewis - Children's Healthcare of AtlantaKaren A. Matthews - University of PittsburghMaureen Monaghan - George Washington UniversityJennifer G. Robinson - University of IowaDeborah Tate - University of North Carolina at Chapel HillKirsten Bibbins-Domingo - University of California, San FranciscoBonnie Spring - Northwestern University
- Resource Type
- Journal article
- Publication Details
- Journal of the American Heart Association, Vol.9(19), pp.e016115-e016115
- DOI
- 10.1161/JAHA.120.016115
- PMID
- 32993438
- PMCID
- PMC7792379
- NLM abbreviation
- J Am Heart Assoc
- ISSN
- 2047-9980
- eISSN
- 2047-9980
- Publisher
- Wiley
- Number of pages
- 20
- Grant note
- Esperion Acasti Office of Behavioral and Social Sciences Research; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA Jazz Pharmaceuticals R01DK103668; R01DK095078 / NIDDK; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) R01DK108678; R01DK097364 / National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) R01HL122144; R01HL127341; HHSN268201800003I; R01HL121230; R21HL145419; R01HL132148; R01HL14866; R01HL136942; R01HL133860; R01HL128666; R01HL130471; R01HL107475 / NHLBI; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI) P01HD031921 / Eunice Kennedy Shriver National Institute of Child Health and Human Development; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) Kemin Foods 17SFRN33660752; 18SRG343600001 / American Heart Association (AHA); American Heart Association Amgen Sanofi Eli Lilly Nexalin Technology Medicines Company Astra-Zeneca; AstraZeneca K23HL122361 / NHLBI career development award 1-18-ACE-27 / American Diabetes Association Pathway to Stop Diabetes Accelerator Award; American Diabetes Association Merck; Merck & Company Novartis Novo-Nordisk; Novo Nordisk National Heart, Lung, and Blood Institute (NHLBI); United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI) 16SFRN28930000; 19SCG34940002; 18SCG34350001; 14SFRN20740001 / AHA; American Heart Association R01MD011600 / National Institute of Minority Health and Health Disparities; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute on Minority Health & Health Disparities (NIMHD) 3092-5-001-057 / US Department of Agriculture's Agricultural Research Service Current Research Information System Award Amarin Regeneron
- Language
- English
- Date published
- 10/20/2020
- Academic Unit
- Epidemiology; Fraternal Order of Eagles Diabetes Research Center
- Record Identifier
- 9984364414602771
Metrics
16 Record Views